QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.108.053009v1 75/3/454    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Straßer, A. Articles by Seifert, R. Search for Related Content PubMed PubMed Citation Articles by Straßer, A. Articles by Seifert, R.

Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H₁-Receptor Compared with the Guinea Pig H₁-Receptor

Department of Pharmaceutical/Medicinal Chemistry I, School of Pharmacy (A.S., M.K., S. E.) and Faculty of Chemistry and Pharmacy (H.-J.W.), University of Regensburg, Regensburg, Germany; and Institute of Pharmacology, Medical School of Hannover, Hannover, Germany (R.S.)

Previous studies revealed that phenylhistamines and histaprodifens possess higher potency and affinity at guinea pig histamine H₁-receptor (gpH₁R) than at human histamine H₁-receptor (hH₁R). However, we recently identified an imidazolylpropylguanidine [N¹-(3-cyclohexylbutanoyl)-N²-[3-(1H-imidazol-4-yl)-propyl]guanidine (UR-AK57)] with higher potency and efficacy at hH₁R compared with gpH₁R. The aim of this study was to reveal the molecular basis for the species differences of synthetic ligands. We studied 11 novel phenylhistamines and phenoprodifens. H₁R species isoforms were expressed in Sf9 insect cells, and [³H]mepyramine competition binding and GTPase assays were performed. We identified bulky phenylhistamines with higher potency and affinity at hH₁R compared with gpH₁R. Molecular dynamics simulations of ligand-H₁R interactions revealed four potential binding modes for phenylhistamines possessing an additional histamine moiety; the terminal histamine moiety showed a high flexibility in the binding pocket. There are striking similarities in ligand properties in bulky phenylhistamines and UR-AK57. Comparison of bulky phenylhistamine binding mode with binding mode of UR-AK57 suggests that only one of these four binding modes should be established. The higher potency is explained by more effective van der Waals interaction of the compounds with Asn^2.61 (hH₁R) relative to Ser^2.61 (gpH₁R). In addition, two stable binding modes for phenoprodifens with different orientations in the binding-pocket were identified. Depending on phenoprodifen orientation, the highly conserved Trp^6.48, part of the toggle switch involved in receptor activation, was found in an inactive or active conformation, respectively. We identified the first phenylhistamines with higher potency at hH₁R than at gpH₁R and obtained insight into the binding mode of bulky phenylhistamines and imidazolylpropylguanidines.

Received for publication October 23, 2008.

Accepted for publication December 1, 2008.

Address correspondence to: Dr. Andrea Straßer, Department of Pharmaceutical and Medicinal Chemistry I, University of Regensburg, Universitä-tsstraße 31, D-93053 Regensburg, Germany. E-mail: andrea.strasser{at}chemie.uni-regensburg.de

This article has been cited by other articles:

				K.-F. Deml, S. Beermann, D. Neumann, A. Strasser, and R. Seifert Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor Mol. Pharmacol., November 1, 2009; 76(5): 1019 - 1030. [Abstract] [Full Text] [PDF]

				H.-J. Wittmann, R. Seifert, and A. Strasser Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor Mol. Pharmacol., July 1, 2009; 76(1): 25 - 37. [Abstract] [Full Text] [PDF]